174 related articles for article (PubMed ID: 27585789)
21. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
22. Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc
He Z; Chen L; Souto FO; Canasto-Chibuque C; Bongers G; Deshpande M; Harpaz N; Ko HM; Kelley K; Furtado GC; Lira SA
Sci Rep; 2017 Jul; 7(1):5520. PubMed ID: 28710436
[TBL] [Abstract][Full Text] [Related]
23. Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands.
Choi T; Ferris ST; Matsumoto N; Poursine-Laurent J; Yokoyama WM
J Immunol; 2011 Apr; 186(7):3911-7. PubMed ID: 21335486
[TBL] [Abstract][Full Text] [Related]
24. Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.
Ravillah D; Mohammed A; Qian L; Brewer M; Zhang Y; Biddick L; Steele VE; Rao CV
J Pharmacol Exp Ther; 2014 Jan; 348(1):59-68. PubMed ID: 24218540
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
[TBL] [Abstract][Full Text] [Related]
27. Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model.
Zhang J; Sud S; Mizutani K; Gyetko MR; Pienta KJ
Neoplasia; 2011 Jan; 13(1):23-30. PubMed ID: 21245937
[TBL] [Abstract][Full Text] [Related]
28. A gnotobiotic transgenic mouse model for studying interactions between small intestinal enterocytes and intraepithelial lymphocytes.
Mysorekar IU; Lorenz RG; Gordon JI
J Biol Chem; 2002 Oct; 277(40):37811-9. PubMed ID: 12138109
[TBL] [Abstract][Full Text] [Related]
29. Functional Characterization of Ly49
Shytikov D; Rohila D; Li D; Wang P; Jiang M; Zhang M; Xu Q; Lu L
Front Immunol; 2020; 11():602783. PubMed ID: 33488602
[TBL] [Abstract][Full Text] [Related]
30. Effect of anti-mouse CD52 monoclonal antibody on mouse intestinal intraepithelial lymphocytes.
Qu L; Li Q; Jiang H; Gu L; Zhang Q; Wang C; Li J
Transplantation; 2009 Sep; 88(6):766-72. PubMed ID: 19920775
[TBL] [Abstract][Full Text] [Related]
31. The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands.
Ma BJ; Craveiro Salvado CM; Kane KP
Immunogenetics; 2014 Aug; 66(7-8):467-77. PubMed ID: 24797174
[TBL] [Abstract][Full Text] [Related]
32. Analysis of intestinal intraepithelial lymphocyte populations in experimental Trichinella spiralis infection of mice.
Bozić F; Marinculić A; Duraković E
Folia Parasitol (Praha); 2000; 47(1):55-9. PubMed ID: 10833017
[TBL] [Abstract][Full Text] [Related]
33. A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice.
Ploplis VA; Tipton H; Menchen H; Castellino FJ
J Pathol; 2007 Nov; 213(3):266-74. PubMed ID: 17893885
[TBL] [Abstract][Full Text] [Related]
34. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
35. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
[TBL] [Abstract][Full Text] [Related]
36. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
37. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
38. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development.
Maran RR; Thomas A; Roth M; Sheng Z; Esterly N; Pinson D; Gao X; Zhang Y; Ganapathy V; Gonzalez FJ; Guo GL
J Pharmacol Exp Ther; 2009 Feb; 328(2):469-77. PubMed ID: 18981289
[TBL] [Abstract][Full Text] [Related]
39. Determining ligand specificity of Ly49 receptors.
Lavender KJ; Kane KP
Methods Mol Biol; 2010; 612():299-311. PubMed ID: 20033649
[TBL] [Abstract][Full Text] [Related]
40. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
